×
HeartBeam EBITDA 2020-2024 | BEAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
HeartBeam ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
HeartBeam EBITDA 2020-2024 | BEAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
HeartBeam ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$8.5B
Inspire Medical Systems (INSP)
$5.3B
Hims & Hers Health (HIMS)
$5.1B
Privia Health (PRVA)
$2.5B
Enovis (ENOV)
$2.5B
IRhythm Technologies (IRTC)
$2.4B
Azenta (AZTA)
$2B
Omnicell (OMCL)
$2B
Clover Health Investments (CLOV)
$1.6B
10x Genomics (TXG)
$1.6B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.1B
Butterfly Network (BFLY)
$650M
Standard BioTools (LAB)
$562M
Talkspace (TALK)
$522M
Fulgent Genetics (FLGT)
$520M
Definitive Healthcare (DH)
$483M
Health Catalyst (HCAT)
$459M
TruBridge (TBRG)
$244M
Pulmonx (LUNG)
$237M
SOPHiA GENETICS SA (SOPH)
$214M
American Well (AMWL)
$122M
EUDA Health Holdings (EUDA)
$107M
P3 Health Partners (PIII)
$75M
111 (YI)
$53M
CareCloud (CCLD)
$46M
Zepp Health (ZEPP)
$40M
SHL Telemedicine (SHLT)
$40M
Outset Medical (OM)
$39M
Movano (MOVE)
$20M